@bedger , Possible partnership with J&J it is mostly speculation?
What do you think in the event that a partnership is not formed with J&J, in regards to the value of OCC and short/long term
future of OCC?
Also, In late April/ early May OCC had a CR for $10.4M to be used to fast track marketing.
Following that OCC had a few annies , such as dental. We saw SP get up to 57c. Obviously based on the annies.
Based on those annies the SP didn't slide down all the way back down straight away.
What would be a fair time frame for OCC to justify the CR to fast track marketing? (As we require OCC to increase revenue and profits to keep
the SP higher.)
Ann: CelGro Nerve Regeneration Results in Quadriplegic Patients, page-256
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.45M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 37.0¢ | $34.15K | 92.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14000 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 20208 | 2 |
View Market Depth
| Last trade - 10.07am 10/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |